Becton Dickinson stock awaits fiscal 2026 results on November 5

Becton Dickinson will discuss its fourth-quarter and full-year fiscal 2026 results on Thursday, November 5, after the fiscal year ended September 30. In an investor-relations release dated October 8, BD said management would host an audio webcast at 8 a.m. Eastern Time to review the results and provide an update on operations and strategy.

Fiscal Results Take Center Stage

The company said it would publish summary financial information and presentation materials before the webcast. The event covers the quarter and full fiscal year ended September 30, making the release the next major checkpoint for investors assessing BD's operating performance and outlook.

Becton Dickinson stock traded at 186.13 euros on Lang & Schwarz at 11:00 p.m. CET on Wednesday, November 4, 2026. Investors can follow the real-time quote of Becton Dickinson stock.

Business Profile and Position

BD describes itself as one of the world's largest pure-play medical technology companies. Its portfolio spans medical essentials, connected care, biopharma systems and interventional products, serving healthcare customers worldwide. The company says it has more than 60,000 employees and delivers billions of products annually across global markets.

The broader US equity market is represented by the S&P 500.

More news and analyses on Becton Dickinson stock